The US Food and Drug Administration (FDA) is confronted with significant challenges in its inspection processes due to recent layoffs. Among ...

The US Senate Judiciary Committee advanced to the full Senate six bills intended to reduce pharmaceutical prices and enhance market competitiveness. The package collectively targets several aspects of ...

According to market estimates for 2024 to 2034, demand for regulatory information management systems is likely to register a ...

The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

The ban was issued after the regulator found that some FDC drugs were licensed for manufacture, sale and distribution without ...

Blockchain tools are comparable to wildfire – fast-moving and capable of consuming?anything that lies in their path.

The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.